Paper9875583
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Mwinga A and 11 others. AIDS, 1998. Cited by 199 papers, by iCite.
Cite this record
ConductScience Library. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. Papers, record 9875583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9875583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS-Related Opportunistic Infections | Major topic |
| Antibiotic Prophylaxis | Major topic |
| Antitubercular Agents | Major topic |
| Isoniazid | Major topic |
| Pyrazinamide | Major topic |
| Rifampin | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Adult | |
| Antibiotics, Antitubercular | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Patient Compliance | |
| Treatment Outcome | |
| Tuberculin Test | |
| Zambia |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 199 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39374926 | Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea. | Tuberc Respir Dis (Seoul) | 2025 | https://conductscience.org/library/papers/39374926 | PubMed |
| 37444057 | Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/37444057 | PubMed |
| 35769848 | Mycobacterial infections in solid organ transplant recipients. | Korean J Transplant | 2021 | https://conductscience.org/library/papers/35769848 | PubMed |
| 34903214 | Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis. | BMC Med | 2021 | https://conductscience.org/library/papers/34903214 | PubMed |
| 34520459 | Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis. | PLoS Med | 2021 | https://conductscience.org/library/papers/34520459 | PubMed |
| 33579394 | Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania. | Trop Med Health | 2020 | https://conductscience.org/library/papers/33579394 | PubMed |
| 32918195 | Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB. | Curr HIV/AIDS Rep | 2020 | https://conductscience.org/library/papers/32918195 | PubMed |
| 32411454 | Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study. | AIDS Res Treat | 2020 | https://conductscience.org/library/papers/32411454 | PubMed |
| 31364692 | Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. | Am J Epidemiol | 2019 | https://conductscience.org/library/papers/31364692 | PubMed |
| 30885144 | Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015. | BMC Infect Dis | 2019 | https://conductscience.org/library/papers/30885144 | PubMed |
| 28724374 | Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study. | BMC Public Health | 2017 | https://conductscience.org/library/papers/28724374 | PubMed |
| 28409555 | Treatment of Latent Tuberculosis Infection. | Microbiol Spectr | 2017 | https://conductscience.org/library/papers/28409555 | PubMed |
| 26352882 | High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo. | AIDS | 2015 | https://conductscience.org/library/papers/26352882 | PubMed |
| 26258564 | Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana. | J Acquir Immune Defic Syndr | 2015 | https://conductscience.org/library/papers/26258564 | PubMed |
| 25768869 | Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature. | J Acquir Immune Defic Syndr | 2015 | https://conductscience.org/library/papers/25768869 | PubMed |
| 25365974 | Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25365974 | PubMed |
| 23535699 | Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study. | BMJ Open | 2013 | https://conductscience.org/library/papers/23535699 | PubMed |
| 23382740 | HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon. | Afr Health Sci | 2012 | https://conductscience.org/library/papers/23382740 | PubMed |
| 23251327 | Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. | PLoS One | 2012 | https://conductscience.org/library/papers/23251327 | PubMed |
| 22581360 | Treatment of latent tuberculosis infection in HIV: shorter or longer? | Curr HIV/AIDS Rep | 2012 | https://conductscience.org/library/papers/22581360 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9875583
GET https://conductscience.org/api/papers/v1/9875583/cited_by?page=2